Stay updated with breaking news from Esr1 Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drs Mayer and Kalinsky provide insights and offer their impressions of the PADA-1 trial, focusing on ESR1 mutation monitoring with circulating tumor DNA (ctDNA).
Kevin Kalinsky, MD, MS, and Erica L. Mayer, MD, MPH, discuss testing practices for ESR1 mutations in patients with breast cancer.
Experts on breast cancer discuss challenges encountered in biomarker testing for patients with breast cancer.